首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1544754

基因检测市场、机会、成长动力、产业趋势分析与预测，2024-2032

Genetic Testing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月03日 | 出版商:

Global Market Insights Inc. | 英文 276 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于基因组技术的不断推出和进步，2024 年至 2032 年全球基因检测市场规模将以 11.7% 的复合年增长率扩大。

最近，医疗保健产业见证了新的测试解决方案的推出，这些解决方案的准确性更高，并且在医疗保健、个人化医疗和研究方面的应用不断扩大。此外，创新还结合了下一代定序技术和改进的资料分析工具，以提供更深入的遗传见解。例如，2024 年 3 月，BillionToOne 推出了 BabyPeek，这是一种产前基因测试，可提供有关婴儿的非医学见解，例如潜在的眼睛颜色、头髮质地和食物偏好。这项发展凸显了基因检测技术在个人化见解方面所取得的进展。

市场分为产品和服务、测试类型、应用、技术、最终用途和区域。

在产品和服务方面，预计到 2032 年，软体和服务领域的基因检测产业份额将大幅增长。随着软体开发人员精心设计先进的遗传分析工具，遗传服务提供者正在提供对遗传倾向和性状的更深入的见解。这种协同作用简化了遗传资料的解释，使其更加用户友好和可操作。

就最终用途而言，诊断实验室领域的基因检测市场价值预计将在 2024 年至 2032 年期间成长。透过利用先进的演算法和资料分析工具，诊断实验室正在提高遗传结果的准确性和速度。基因检测及其相关技术的不断发展为诊断实验室持续提供增强和个性化的健康见解铺平了道路。

从地区来看，亚太地区基因检测产业预计在 2024 年至 2032 年间将出现显着的复合年增长率，这主要是由癌症发生率不断上升的推动。随着癌症渗透率的激增，对基因检测的需求不断增加，以查明遗传风险并客製化治疗计划。因此，持续的创新旨在提供彻底的癌症风险评估和量身定制的管理策略，根据该地区不断上升的癌症发病率提高结果并支持积极的医疗保健措施。

产业生态系统分析
产业影响力
- 成长动力
  - 技术进步和新测试的可用性
  - 基因检测在肿瘤学和遗传疾病的应用日益广泛
  - 消费者对个人化医疗的偏好不断增加
  - 对直接面向消费者的基因检测的需求不断增长
- 产业陷阱与挑战
  - 基因检测费用高
  - 发展中经济体和已开发经济体缺乏经验丰富的专业人员和先进的基础设施
成长潜力分析
监管环境
技术景观
报销场景
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品和服务划分，2021 - 2032 年

主要趋势
试剂盒和试剂
软体和服务

第 6 章：市场估计与预测：按测试类型，2021 - 2032 年

主要趋势
预测测试
运营商测试
产前和新生儿检测
诊断测试
药物基因组测试
营养基因体学
其他测试类型

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
癌症治疗
移植组织分型
法医身分测试
血统测试
亲子鑑定
其他应用

第 8 章：市场估计与预测：按技术分类，2021 - 2032 年

主要趋势
聚合酶炼式反应
DNA定序
- 桑格定序
- 下一代定序
细胞遗传学检测
- 染色体分析（核型分析）
- 萤光原位杂交（FISH）
微阵列
基因表现谱

第 9 章：市场估计与预测：依最终用途，2021 - 2032 年

主要趋势
医院和诊所
诊断实验室
法医实验室
其他最终用户

第 10 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 11 章：公司简介

23 and ME, Inc.
Abbott Laboratories
Ambry genetics
Ancestry DNA
bioMerieux SA
BGI Genomics
Eurofins Scientific
Illumina, Inc.
Invitae Corporation
Luminex Corporation
Myriad Genetics, Inc.
Natera, Inc.
QIAGEN N.V.
Quest Diagnostics
Siemens Healthineers AG

简介目录

Product Code: 2490

Global Genetic Testing Market size will expand at an 11.7% CAGR from 2024 to 2032, due to increasing launches and advancements in genomic technology.

Recently, the healthcare sector has witnessed the introduction of new testing solutions with enhanced accuracy and expanding applications in healthcare, personalized medicine, and research. Furthermore, innovations are incorporating next-generation sequencing technologies and refining data analysis tools to deliver deeper genetic insights. For example, in March 2024, BillionToOne unveiled BabyPeek, a prenatal genetic test that offers non-medical insights about the baby, such as potential eye color, hair texture, and food preferences. This development underscores the strides made in genetic testing technology for personalized insights.

The market is segregated into product and service, test type, application, technique, end-use, and region.

In terms of product and service, the genetic testing industry share from the software and services segment is expected to witness growth at a significant rate through 2032. This is fuelled by the increasing demand for a transformative approach to health management. As software developers craft advanced genetic analysis tools, genetic service providers are delivering deeper insights into genetic predispositions and traits. This synergy simplifies the interpretation of genetic data, making it more user-friendly and actionable.

In terms of end-use, the genetic testing market value from the diagnostic laboratories segment is anticipated to grow from 2024 to 2032. This is attributed to the push for advanced genetic testing through the adoption of state-of-the-art technologies and software solutions. By leveraging advanced algorithms and data analysis tools, diagnostic laboratories are boosting the accuracy and speed of genetic results. The continuous evolution in genetic testing and its associated technologies is paving the way for diagnostic laboratories to consistently offer enhanced and personalized health insights.

Regionally, the Asia Pacific genetic testing industry is set to experience a notable CAGR between 2024 and 2032, primarily driven by the escalating incidence of cancer. With this surging cancer penetration, there is an increasing demand for genetic testing to pinpoint hereditary risks and customize treatment plans. Consequently, the ongoing innovations aim to provide thorough cancer risk evaluations and tailored management strategies, enhancing outcomes and bolstering proactive healthcare measures in light of the rising cancer rates in the region.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advancement and availability of new tests
  - 3.2.1.2 Growing application of genetic testing in oncology and genetic diseases
  - 3.2.1.3 Increasing consumer preference for personalized medicine
  - 3.2.1.4 Growing demand for direct-to-consumer genetic testing
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of genetic testing
  - 3.2.2.2 Dearth of experienced professionals and advanced infrastructure in developing and developed economies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product and Service, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Kits and reagents
5.3 Software and services

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Predictive testing
6.3 Carrier testing
6.4 Prenatal and newborn testing
6.5 Diagnostic testing
6.6 Pharmacogenomic testing
6.7 Nutrigenomics
6.8 Other test types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Cancer treatment
7.3 Tissue typing for transplantation
7.4 Forensic identity testing
7.5 Ancestry testing
7.6 Paternity testing
7.7 Other applications

Chapter 8 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Polymerase chain reaction
8.3 DNA sequencing
- 8.3.1 Sanger sequencing
- 8.3.2 Next generation sequencing
8.4 Cytogenetic testing
- 8.4.1 Chromosome analysis (karyotyping)
- 8.4.2 Fluorescence in situ hybridization (FISH)
8.5 Microarrays
8.6 Gene expression profiling

Chapter 9 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Hospitals and clinics
9.3 Diagnostic laboratories
9.4 Forensic laboratories
9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa